2Evans DB.Overview of cardiovascular physiologic and pharmacologic as-pect ofselective phophodiesterase peadⅢinhibitors.Am J Cardiol,1989;63:9A.
3Monrad ES,McKay RG,Baim DS,et al.Improvement in indexes of dias-tolicperformance in patients with congestive bean failure treated with milrinone.Circulation,1984;70:1030-1037.
4Benotti JR,Lesko LJ,McCue JE,et al.Pharmacokinetics and pharmaco-dynamics ofmilrinone in chronic congestive heart failure.Am J Cardiol,1985;56:685-689.
6Vandefl'-c.den M,Vrinls C, Verstreken S, et akB-type nalriuretie pep6de as a marker of heart -]ure:rmv k-l'as fara - md - [J].Biom- Med2.010;4(4):31 -320.
